CALC
CALC clinical trials: CalciMedica, Inc.
Every trial on ClinicalTrials.gov where CalciMedica, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 8
- Trials linked
- 7
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CALC on the catalyst calendar · CALC registry changes
- Primary completion Apr 6, 2026ActualPhase 2NCT06374797A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"CalciMedica, Inc. · Acute Kidney InjuryTerminatedCALCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 21, 2021ActualPhase 2NCT04661540A Study of Auxora in Patients With Critical COVID-19 PneumoniaCalciMedica, Inc. · PneumoniaTerminatedCALCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 15, 2024ActualPhase 2NCT04681066A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRSCalciMedica, Inc. · Acute PancreatitisCompletedCALCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 28, 2021ActualPhase 2NCT04345614A Study of Auxora in Patients With Severe COVID-19 PneumoniaCalciMedica, Inc. · PneumoniaCompletedCALCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 14, 2019ActualPhase 2NCT03401190CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRSCalciMedica, Inc. · Acute PancreatitisCompletedCALCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 7, 2019ActualPhase 2NCT03709342A PK/PD Study of CM4620-IE in Patients With Acute PancreatitisCalciMedica, Inc. · Acute PancreatitisCompletedCALCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2022Sponsor estimatePhase 2NCT05171920A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 PneumoniaCalciMedica, Inc. · PneumoniaWithdrawnCALCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimatePhase 1/Phase 2NCT04195347Study of CM4620 to Reduce the Severity of Pancreatitis Due to AsparaginaseSt. Jude Children's Research Hospital · Acute PancreatitisRecruitingCALCCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner